Portfolio Finder

GS Bavaria is the world‘s first supplier of nano- hard metal materials on industrial scale. Production is extremely cost-efficient, sustainable and comes with minimal energy consumption through our unique bioleaching recycling process. This process yields nano- powders which we transform into nano- additives to make it as easy as possible for our customers to produce high-performance composites. For now, additives based on Tungsten (W) are available, other metals to come.

Hanko.io enables the switch to secure and completely passwordless multifactor authentication. The company is a member of the international FIDO Alliance and the first European provider of a certified FIDO solution. With the FIDO Developer API Hanko addresses especially software developers in companies. The customers include international software and cloud providers, the public sector and companies from the financial and healthcare sectors.

Hapila's counter-current crystallisation process provides a cost effective procedure for purification of active pharmaceutical ingredients, completed by experience in synthesis and particle design.

HBOX Therapies has developed a technology that facilitates lung-protective treatment of respiratory patients, the patented platform technology HBOX (Hyperbaric Blood Oxygenation). The management team of HBOX Therapies consists of the founders and shareholders Dr. Peter Schlanstein, Dr. Matthias Menne and Niklas Steuer. Before founding the company, they worked together for many years at the Institute for Applied Medical Technology (AME) at RWTH Aachen University and are highly specialized in their fields.

heartbeat ONE provides a streamlined patient management tool for health care facilities of all sizes. It offers intelligent evaluations of diagnostics and treatment methods. It supports the preparation, documentation and evaluation of medical interventions. Patient reported outcomes can automatically be collected for every patient. heartbeat ONE is hosted for customers in certified data centers in Germany or if desired self hosted on site.
Fully web-based the system heartbeat ONE runs on all major operating systems and requires only a modern browser. The integrated medical documentation has been enhanced by an algorithm that dynamically adapts to the treatment situation. In order to conduct patient surveys and a digital anamnesis via tablet at cite, native applications for iOS and Android platforms are available. Follow-up patient surveys are carried out over a separate patient portal which can be accessed from all devices (pc, smartphone, tablet, etc.).

Heidelberg Epignostix is a healthcare company whose mission is to transform cancer diagnostics through data science. The company has developed novel AI-based bioinformatics algorithms with utility in cancer classification for improved accuracy in cancer diagnosis, prognosis and therapy management. The lead product, the Heidelberg Brain Classifier, is currently available as a research-use-only resource. Heidelberg Epignostix is located in Heidelberg, Germany. For more information visit www.epignostix.com.

Heliatek GmbH, a spin-off of the Technical University Dresden and the University of Ulm. heliatek focusses on research and development and perspectively with the production of organic solar cells for electricity generation.

hema.to is an easy-to-use software for clinical decision support for blood cancer from cytometry data using AI. hema.to makes the diagnostic workflow both faster and better, helping both diagnosticians as well as patients. hema.to is a CE-IVD, FDA registered and already in routine use by leading hematology laboratories. Founded in 2021, hema.to’s mission is to make clinical analysis of cytometry data completely objective, to enable doctors to personalize treatment to their patient’s unique immune system.

Since its operational start in 2017, HepaRegeniX has successfully discovered and developed several drug candidates for the treatment of acute and chronic liver diseases based on a novel proprietary molecular target Mitogen-Activated Protein (MAP) Kinase Kinase 4 (MKK4). A first compound has recently started clinical development.
MKK4 is a key regulator of liver regeneration and suppression of MKK4 unlocks the regenerative capacity of hepatocytes even in severely diseased livers. This new and unique therapeutic concept for the treatment of liver diseases was discovered by Prof. Lars Zender and his research group at the University Hospital Tubingen, Germany. Investors in HepaRegeniX include the Boehringer Ingelheim Venture Fund (BIVF), Novo Holdings A/S, Coparion, High-Tech Gruenderfonds and Ascenion GmbH.

HighLine Technology GmbH develops and commercializes high-precision printing technology for the semiconductor industry. The current focus is the introduction of the parallel dispensing technology for the metallization of solar cells. The dispensing print heads enable parallel and homogeneous printing of high aspect ratio contact linesat finger widths below 30 µm. HighLine’s Dispensing Print Heads thereby enable the reduction of material costs at increased production throughputs for the application of print media. In addition, HighLine develops automation solutions for the integration of print heads in existing production platforms and thus cooperates with established automation manufacturers. The core competences of the company are component and process development for dispensing technologies.

Hofmann & Stirner Zuführsysteme GmbH was founded in 2016 by Daniel Hofmann and Florian Stirner. The company develops powerful and flexible feeding systems using digital twins and artificial intelligence. Hofmann & Stirner work closely together with well-known companies in machine and plant construction.
More: www.designforfeeding.com

Hornetsecurity is premium provider of cloud-based security services. Hornetsecurity products protect companies’ IT infrastructure and data.

Founded in March 2017 and based in Grenoble (France), Hprobe is a spin-off company of SPINTEC (one of the leading spintronics research laboratories worldwide) and benefit from many years of research in the field of magnetic testing. Hprobe is today able to offer a unique patented technology of multidimensional magnetic field generator for magnetic devices and sensors wafer level characterization and testing. Current product line includes dedicated tools for characterization and testing of MRAM (STT, SOT, VCMA) and Magnetic Sensors (TMR, GMR, etc.) in all phases of the magnetic technology development. The company is currently working with all major foundries worldwide involved in the manufacturing of MRAM devices.

HQ plus – the new generation of competitive intelligence for hotels.

HQS Quantum Simulations predicts material properties using quantum computers. The company accelerates development cycles in the chemistry and pharma industries. Quantum computers can perform calculations impossible even for the most powerful supercomputers. Current quantum computers suffer from intrinsic errors that limit their performance. The HQS Team developes algorithms for quantum computers that can deal with these errors and enable our customers to profit from the performance advantage of quantum computers earlier than their competitors. Furthermore, HQS offers individual simulation solutions for conventional computers with an integration of high-end simulation methods and the possibility to utilize the upcoming quantum computers.

Humedics markets a system for bedside and instantaneous measurement of liver function. Patented device, consumables and a diagnostic drug allow an optimal market offering.

Hypros (formerly GWA Hygiene) is committed to reducing the number of hospital infections. For this purpose, the company has developed NosoEx, a modern monitoring system for measuring hand hygiene. The IoT system can be seamlessly integrated into the infrastructure of the health facilities. For this purpose, the existing disinfectant dispensers are equipped with sensors. The software can then be used to see how the disinfection figures for each station, donor and occupational group are developing. Measures to improve the hygiene situation can then be initiated.
The Stralsund start-up was founded in 2015 and now has 25 employees. In addition to Maik Gronau and Tobias Gebhardt, Dirk Amtsberg, Marcel Walz and Daniel Neuendorf are among the founding partners. The NosoEx system is currently being used by a double-digit number of customers in Europe.
The NosoEx system is currently being used by a double-digit number of customers in the DACH region.

i3 Membrane is a companion for filtration solutions and separation technologies in life science. With and for the customers, high-quality products in the fields of medical, lab / pharma and biotech are developed. By combining ion and membrane technology and with the help of plasma immersion ion implantation, the first digitally controllable membrane was developed for the i3 as early as 2013 and traditional separation technology was revolutionized.

The membranes equipped with functionalized surfaces enable more efficient and sustainable separation processes and reduce fouling. The digitally switchable adsorption and desorption of various media with simultaneous filtration opens up new possibilities for using membranes in all areas of life sciences. Coated polymer membranes are used for both individual and standardized solutions in healthcare, laboratory technology and pharmaceuticals as well as in research. The range of applications extends from Analytics through Infection prevention to Biotechnology.

Today i3 Membrane is one of the most innovative separation technology companies. Production takes place at the headquarters in Radeberg near Dresden. The young company is characterized by its branches in Germany and Austria and an international sales network.

iAtros is a digital heart clinic and a fully integrated platform, providing better medical care for patients with cardiovascular problems around the clock. Among other services, iATROS offers smart sensor diagnosis, a vital parameter data base, therapy- and medication regimes as well as teledoctor services.
Cardiologists Prof. Dr. med. Alexander Leber and Dr. med Georges von Degenfeld and eHealth entrepreneur Patrick Palacin founded iATROS in 2019. Former Sky executive and communications expert Prof Wolfram Winter and former AOK Berlin finance director Jens Schäfer are the co-founders.

Lighting as a Service: Intelligent lighting with M2M (Machine to Machine) services in outdoor sector with focus on Information, Communication, Energy efficiency (ICE).

Exit since November 2016.

ICO-LUX was founded in 2018 as a spin-off of the Friedrich-Schiller-University Jena and the TU Ilmenau and is specialized in software for automated document forensics. With ICO.Fraud for private health insurance companies, the start-up is the only provider of a software solution for fully automatic detection of forged documents to date. Customers are currently mainly private health insurance companies. ICO-LUX has 7 employees at its Jena site, including mathematicians, physicists and computer scientists with doctorates.

Immunic Therapeutics is a clinical-stage biotech company with a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. Immunic, Inc. is headquartered in New York. Its subsidiary, Immunic AG, is based in Graefelfing near Munich, Germany, where the company’s research and development activities are conducted. Additional subsidiaries are located in Halle/Saale, Germany, and Melbourne, Australia.

Immunic is developing three small molecule products: lead development program, IMU-838, is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORγt; and IMU-856 targets the restoration of the intestinal barrier function. IMU-838 is in phase 2 clinical development for COVID-19, relapsing-remitting multiple sclerosis, ulcerative colitis and, in collaboration with the Mayo Clinic, primary sclerosing cholangitis.

IOP GmbH will initiate a paradigm chance in glaucoma therapy by its products for telemetric, 24 hour monitoring of intraocular pressure, allowing personalized patient management.

Implisense offers a solution for lead generation as well as cross- and upselling for B2B marketing and sales. Their self-developed company index, which is kept up-to-date on a day-to-day basis and stores information about several million companies in Germany is the foundation of their solution. Users can obtain access to this index via a Web-based interface and perform their own customer and market analysis. The solution can compute a target profile based on examples of a user’s existing customers. With the help of this profile the solution can recommend new potential customers as well as cross- and upselling opportunities immediately.

Error-prone manual labor and frustrating communication loops – to date, large companies need multiple days to publish a new app version. With incapptic Connect it's a matter of seconds: Our software simplifies the data exchange with external developers. incapptic Connect signs automatically with your enterprise's private keys. incapptic Connect is compatible with popular app distribution systems such as MobileIron, Apple App Store and Google Play. It enables large enterprises to move as fast as startups. incapptic Connect saves you money, time, and sanity.

InCephalo develops exclusively local treatments for neurological diseases, with a focus on cancers in the brain (primary brain cancers as well as secondary brain cancers). The proprietary Compartment Lock technology, also called C-Lock, retains biologics, that are applied locally behind the blood brain barrier, in the central nervous system (CNS) and once they leave the CNS, degrades them rapidly in the systemic compartment. Thereby it significantly improves local CNS therapy, a challenging task with regards to achieving high local concentration (for efficacy) and low systemic footprint (to reduce potential side effects). Especially the peripheral side effects still limit various promising candidates for the treatment of brain cancer or other neurological diseases.

InCirT is a deep-tech start-up which provides semiconductor IP solutions for high-speed wireless networks. The core product of the company is a digital-analog / analog-digital converter (a so called “transceiver”), which in its final version will enable data transmission of up to 1 Tbps. The company was started at RWTH Aachen. It was founded in the beginning of 2022 while participating in the EXIST technology transfer program. The InCirT founder team consists of Dr. Oner Hanay, Dr. Erkan Bayram, Dr. Mohamed Saeed Elsayed, Sebastian Waters und Univ.-Prof. Dr. sc. techn. Renato Negra.

inContAlert was founded in September 2022 within the ecosystem of the University of Bayreuth. The MedTech startup's sensor system empowers patients with neurogenic bladder dysfunction to manage their bladder on a needs-based basis.

Founded by Thilo Hardt and Tony Twyman, two veterans of the startup ecosystem of Berlin. Hardt co-founded Mister Spex, Europe’s leading online optician in 2007, and founded eWings.com, a business travel management software company in 2013, now part of American Express GBT. Both are software developers at heart and eager to make great games that a new generation of kids will soon recall as part of their youth.

Renewable electricity and yet unused, undervalued gases (e.g. CO2) can be converted into sustainable products such as climate neutral gasoline, clean Diesel and e-kerosene, high-quality waxes, green methanol or renewable synthetic natural gas (altogether: e-products). INERATEC (IC) sells compact plants for these conversions or invests into e-product production sites.
IC´s technology solves several challenges of the energy transition: management of a fluctuating supply of renewable energy, large and long-term energy storage as well as sustainable mobility and climate neutrality. Synthetic fuels will especially be needed for heavy-duty and maritime transportation as well as aviation. E-products are a viable option for the defossilization of many industries currently depending on fossil resources.